Marketresearchnews

Wednesday, 6 February 2019

Bone Density Test Market Volume Forecast and Value Chain Analysis 2018

Market Synopsis of the Global Bone Density Test Market

Bone density test is performed to diagnose various bone related diseases such as osteoporosis, osteopenia, and others diseases acting as risk factors for low density of the bones. Osteoporosis, also known as old woman's disease”, is a diseased condition characterized by weakened bones, which are likely to be broken. The condition may also result into bone fracture, which commonly occur in the hip, and spine. The prevalence of this disease is high women but some men may also develop osteoporosis.

Bone density test determines the density of bones and chances of the bone being broken. Central dual-energy X-ray absorptiometry (DXA) test is recommended for testing the bone density of hip and spine. Bone density test used in the diagnosis of osteoporosis, and osteopenia. The osteoporosis mostly occurs in women after the menopause but may also be present in males. The condition is less common in adults and children.

Rising prevalence of osteoporosis, osteopenia, hyperthyroidism, and increasing demand for portable bone testing devices drive the market growth. Furthermore, the demand for diagnosis and treatment measures for osteoporosis also influence the market growth. Additionally, the demand for technologically advanced devices drives the market growth.

According to the International Osteoporosis Foundation, osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds across the globe. It also stated that osteoporosis affected an estimated 75 million people in Europe, the US, and Japan.

The global bone density test market is expected to grow at a CAGR of 7.2% during the forecast period.

Key Players in the Global Bone Density Test Market

Some of the key players in this market are General Electric Company (U.S.), Hologic Inc. (U.S), BeamMed Ltd. (Israel), Swissray (U.S.), Osteosys Corp (South Korea), DMS Imaging (France), Medonica Co. LLTb (South KOrea), Osteometer Meditech Inc. (U.S), and Lone Oak Medical Technologies, LLC (U.S.)

Segments

The global bone density test market is segmented on the basis of type, indication, devices, and end user.

On the basis of the type, the market is segmented into Central dual-energy x-ray absorptiometry (DXA), peripheral tests, radiographic absorptiometry, and others.

Peripheral tests is further segmented into peripheral dual energy X-ray absorptiometry (pDXA), quantitative ultrasound (QUS), and peripheral quantitative computed tomography (pQCT).

On the basis of the indication, the market is segmented into osteoporosis, osteopenia, hyperthyroidism, hyperparathyroidism, and others.

On the basis of devices, the market is segmented into central DEXA scan machine and hand held devices.

On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, and others.

Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/bone-density-test-market-4766

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Bone Biopsy Market - Granular Market Report and Review, 2018

Market Scenario

Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from last few years.

Increasing prevalence of chronic diseases such as Chronic Kidney Disease (CKD) and demand new diagnostic services drives the market growth. Additionally, increasing research and development activities, technological advancements to identify the causes and risk factors associated with osteopenia and osteoporosis also fuel the market growth of global market.

The Global Bone Biopsy Market is expected to grow at a CAGR of 5.7% during the forecast period.

According to the World Health Organisation (WHO), cancer was the leading cause of the total number of deaths globally as of 2015 and was responsible for 8.8 million deaths. The most common causal agents identified are cigarettes, cigars, pipes and chewing tobacco. According to the Cancer Research U.K, looking at the lifestyle factors responsible, it has been found that out of 3 diagnosed cases, 1 may be linked to smoking.

Key Players in the Global Bone Biopsy Market

C R Bard (U.S.),
Becton,
Dickinson and Company (U.S.),
Braun Melsungen AG,
Hologic, Inc. (U.S.),
Cook Medical (U.S.),
Devicor Medical Products Inc. (U.S.),
Argon Medical Inc. (U.S.)

Segments

The global bone biopsy market is segmented on the basis of type, indication and end user.

On the basis of the component, market is segmented into needle biopsy and open biopsy.

On the basis of the application, the market is segmented into bone cancer, bone infection, chronic kidney disease, osteoporosis, and others

On the basis of the end user, the market is segmented into hospital & clinics, surgical centers, diagnostic centers, and others.

Regional Analysis of the Global Bone Biopsy Market

America holds the first position in the bone biopsy market owing to the rising prevalence of cancer in the U.S. and increasing demand for new cancer diagnostic and treatment services. In Americas, North America is the largest market owing to the presence of key players in healthcare diagnostic industry. The prevalence of osteoporosis is found to be higher in the population over 35 years for age. Changing lifestyle, emphasis on fitness and exercise, and overall development of medical device industry also accelerate the growth of the market.

Europe is the second largest market for bone biopsy. In Europe, there is an increasing demand for advanced bone biopsy devices, and extensive research and development activities by clinical research and academic institutes for cancer diagnosis and treatment. Germany is the largest market followed by France. The market in Germany is driven by increasing demand for specialty care services.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the high prevalence of chronic disease such as kidney disease, obesity, diabetes and other. India, China, and Japan are major contributors to the growth of the market. This growth is attributed to an increasing demand of technologically advanced medical devices in diagnostic centers and availability of highly qualified medical professional dedicated to research in oncology. Additionally, rising healthcare expenditure and extensive growth of medical device industry also influence the use of medical devices for diagnosis of various diseases such as osteoporosis, diabetes, cancer, and others.

The Middle East & Africa also show a steady rise in the market owing to low technology penetration and increasing awareness about cancer treatment. In the Middle East & Africa, United Arab Emirates captures the largest market share for bone biopsy owing to the availability of better healthcare infrastructure and a wide scope for research. In Africa, the market also shows a positive growth owing to development of healthcare system in African countries, and increasing demand for primary care services.

Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/bone-biopsy-market-5341

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Blood Collection Market Growth and Restrain Factors Analysis By 2023

Market Scenario:

Global Blood Collection Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 7.46 million in 2017 and is projected to grow at a CAGR of 6.1% over the forecast period. Blood collection plays an important role in the treatment of patients. It persists as a diagnostic tool in laboratory medicine.In most of the cases, blood is usually collected to perform a variety of laboratory tests. Among all the types of blood collection devices, Capillary Blood Collection is simple and relatively painless procedure for clinical testing.

Rising demand for early diagnosis of chronic conditions is one of the key factors driving the blood collection market. According to the Centres for Disease Control and Prevention (CDC), in 2017 nearly 30.3 million people had diabetes out of which 23.1 million people were diagnosed with diabetes while 7.2 million people remain undiagnosed in the United States. Various other factors such as rising awareness about blood sampling, favourable medical device regulation, developing healthcare infrastructure, increasing research & development activities related to healthcare and favourable reimbursement and funding policies are also expected to propel the growth of the market. However, the injury caused during blood collection, blood contaminations, and other complications

can hinder the market growth over the forecast period. There are several potential complications related to blood collection procedure such as, Haematoma or excessive bleeding, arteriospasm or involuntary contraction of the artery, nerve damage, fainting or a vasovagal response, and others.

Key players:BD, Medtronic, Terumo, Haemonetics, Fresenius, Nipro Medical, Kawasumi Laboratories, F.L. Medical, Greiner Holding, Grifols, B. Braun Melsungen AG, Thermo Fisher Scientific Inc., HTL-STREFA S.A., Sarstedt AG & Co and others are some of the key players in the global blood collection market.
Segmentation:The Global Blood Collection Market has been segmented into type of blood collection, product, method, and end user.The market, on the basis of type of blood collection, has been segmented into capillary blood collection, venous blood collection, and vacuum blood collection.The market, by product, has been segmented into blood collection devices, blood collection tubes and collector, needles and syringes, warming devices, blood bags, lancets, and others. The blood collection tubes and collector segment is further classified as serum collection tubes, and plasma or whole blood collection tubes. The plasma or whole blood collection tubes segment includes EDTA tubes, heparin tubes, coagulation tubes, glucose tubes, and ESR tubes. The market, by method, has been segmented into automated blood collection and manual blood collection.

The market, by end user, has been segmented into hospitals & clinics, diagnostic centres and pathology laboratories, home diagnostics, blood banks, and others. The hospitals & clinics segment is anticipated to hold the largest market share owing to the increasing cases of chronic conditions. The diagnostic centres and pathology laboratories are expected to grow at the highest CAGR owing to the ongoing research on better blood sampling approaches.The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The blood collection market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European Blood Collection Market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Blood Collection Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The blood collection market in the Middle East & Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global blood collection market owing to rising healthcare expenditure, increasing cases of chronic conditions and technological advancements in blood collection.

According to the data suggested by Centres for Disease Control and Prevention (CDC) in 2017, 38,739 people received an HIV diagnosis in the US. An antigen/antibody test performed on blood from a vein can usually detect HIV infection 18 to 45 days after an exposure.

Europe is expected to hold the second largest position in the global blood collection market. The market growth in this region is attributed to the government funding and improvement in research & development activities.

The blood collection market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the awareness regarding use of sterile devices for blood collection and rising healthcare spending. According to the World Bank Group, India spent 3.89% of its Gross Domestic Product (GDP) on health.

The Middle East & Africa are expected to hold the least share of the market. The market growth in this region is expected to be driven by rising awareness about blood collection techniques and developing healthcare infrastructure.

Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/blood-collection-market-7013

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Bioinformatics Market 2018 Market Challenge, Driver, Trends & Forecast to 2023

Market scenario:

Bioinformatics is the use of information technology in the field of biotechnology for the purpose of data storage, data warehousing and analyzing the DNA sequences. In bioinformatics technology knowledge about various branches is required which includes biology, mathematics, computer science, laws of physics & chemistry along with it most importantly sound knowledge about information technology is required to analyze biotechnological data.

Globally the market for bioinformatics is growing steadily and has a bright future, this market expected to grow at the rate of about 19.8% till 2022 and this has started since 2016.

Key Players for Bioinformatics Market:

Agilent Technologies,
Illumina, Inc.,
QIAGEN N. V, and Thermo Fisher Scientific Inc.,
Dassault Systèmes,
QIAGEN and others.

Segments:

Bioinformatics market has been segmented on the basis of application which comprises of genomics, chemoinformatics, drug design, transcriptomics, molecular phylogenetics, proteomics, metabolomics, DNA sequences and others. On the basis of services and technology the market is segmented into data warehousing, sequence analysis, sequence manipulation and others. On the basis of sector the market is divided into medical bioinformatics, animal bioinformatics, agriculture bioinformatics and others.

Regional Analysis of Bioinformatics Market:

Globally Americas is the largest market for Bioinformatics. Where in countries like US and Canada play an important role in the growth of the market. Europe is expected to be the second-largest market which is expected to reach US$ XX million by the end of the forecasted period. Furthermore Asia pacific market is expected to be the fastest growing market for Bioinformatics.

Intended Audience

Bioinformatics service providers
Bioinformatics manufacturers
Research and development (R&D) companies
Government research laboratories
Government and independent regulatory authorities

Browse Complete 80 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/bioinformatics-market-2265

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Biochips Market 2018 Market Challenge, Driver, Trends & Forecast to 2023

Market Scenario:

Global Biochips market is expected to grow significantly over the forecast period. The market held a market value of USD 7,300 million in 2017 and is projected to grow at a CAGR of 16.6% over the forecast period. Biochips are intended to function in biological environment, preferably inside living organism.

The factors such as increasing technological advancements in biochips is the major driving factor for the market. Moreover, increasing adoption of personalized medicine, as personalised medicine has many applications in cancer genomics. Furthermore, growing applications of biochips will boost the market growth during forecast period. For instance, biochips can perform thousands of biological reactions operations in few seconds.

However, high cost of the instruments and stringent regulatory guidelines may restrain the growth of the market.

According to national Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people may die from the disease.
Key players:Perkinelmer, Inc., Fluidigm Corporation, Agilent Technologies, Inc., Abbott Laboratories, Bio-Rad Laboratories Inc., Cepheid Inc., Illumina, Inc., GE Healthcare, Thermo Fisher Scientific, Inc, Roche Diagnostics are some of the prominent players in the global biochips market.

Segmentation:The Global Biochips Market has been segmented into type, technology, and end user.

By type, the market has been segmented into DNA chips, lab-on-a-chip, protein chips, cell arrays, and tissue arrays. DNA chips is further segmented into gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, drug discovery, agricultural biotechnology, and others. Lab-on-a-chip is further segmented into clinical diagnostics, genomics, IVD (In-Vitro Diagnostic) & POC (Point of care), Proteomics, Drug Discovery, and others. Protein chips is further segmented into proteomics, expression profiling, diagnostics, high-throughput screening, drug discovery, others.

Based on technology, the market has been segmented into microarrays and microfluidics.

The biochips market, by end user, has been segmented into biotechnology and pharmaceutical companies, hospitals and diagnostics centers, academic & research institutes, and others.

The global biochips market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biochips market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European biochips market has been segmented into Western Europe and Eastern Europe. The Western Europe biochips market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The biochips market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The biochips market in the Middle East & Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global biochips market owing to the high domestic income, and presence of major market players. Moreover, increasing patient population in US. According to American Cancer Society, the overall estimate of 1,735,350 cases for 2018 equals more than 4,700 new cancer diagnoses each day.

Europe is expected to hold the second largest position in the global biochips market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).

The biochips market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of target population in the region.

The Middle East & Africa has the lowest share of the global biochips market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.

Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/biochips-market-7063

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Tuesday, 5 February 2019

Autoimmune Disease Treatment Market Growth and Restrain Factors Analysis By 2023

Definite causes for the development of autoimmune diseases have not been identified. Thus, the emphasis is on the early diagnosis of the disease. Increasing awareness coupled with large-scale prevalence is likely to aid the proliferation of the autoimmune disease treatment market in the foreseeable future.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5586

Expenditures for the treatment of these diseases are on the rise and is poised to exhibit a similar trend in the forthcoming years. As per the National Institutes of Health (NIH), the U.S., the healthcare expenditure for autoimmune diseases has reached half of that of the cancer expenditure. Furthermore, the introduction of favorable policies for insurance reimbursements are anticipated to augment the market over the next couple of years. However, factors such as side effects, counterfeit drugs, and expensiveness of the treatment are forecasted to check the expansion of the autoimmune disease treatment market across the review period.

Autoimmune Disease Treatment Market – Segmental Analysis:

By disease type, the global autoimmune disease treatment market has been segmented into localized, and systemic. The localized segment is further sub-segmented into multiple sclerosis, inflammatory bowel disease, diabetes, and other. The systemic segment is sub-segmented into rheumatoid arthritis, psoriasis, lupus, and others.

By diagnosis, the autoimmune disease treatment market has been segmented into ELISA, dot blot, line blot, agglutination, double immune diffusion, western blotting, multiplex immunoassay, and others.

By therapeutic products, the global autoimmune disease treatment market has been segmented into drugs and therapeutic and monitoring equipment. The drugs segment is further sub-segmented into biologics, immunosuppressant, anti-inflammatory drugs, corticosteroids, and non-steroidal anti-inflammatory drugs.

By distribution channel, the autoimmune disease treatment market is segmented into hospitals & clinics, diagnostic centers, drug stores, pharmacies, and others.

Regional Outlook:

The regional analysis of the autoimmune disease treatment market spans across Asia Pacific, Americas, Europe, and the Middle East & Africa. Americas signifies a huge potential for growth owing to increasing patient population. In addition, the increase witnessed in the expenditures associated with medical facilities is prognosticated to favor the expansion of the market over the next couple of years. The region has been estimated to gain control over the largest share of the global autoimmune disease treatment market in the forthcoming years.

The government of Europe has extended firm support in favor of research & development in the healthcare sector. This, in turn, is likely to pave the way for the growth of the autoimmune disease treatment market in the region. It is expected to place the region on the second spot globally over 2023.

Asia Pacific has unleashed immense opportunities in the market through rapid developments witnessed in the healthcare sector. The population has also created a positive influence on the growth of the autoimmune disease treatment market by increasing its healthcare expenditures.

Autoimmune Disease Treatment Market – Competitive Dashboard:

Some of the prominent players profiled in this MRFR report are Abbott Laboratories, Genentech Inc., Bayer Schering Pharma AG, Amgen Inc., Biogen Idec Inc., Chugai Pharmaceutical Co. Ltd., Danaher, Bio-Rad, Elan Corporation Plc, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, HYCOR Biomedical, Eli Lilly and Company, Johnson & Johnson Inc., Siemens, Squibb Company, Merck & Co. Inc., and Thermo Fisher Scientific.

Industry News:

In January 2019, Cabaletta Bio, launched out of the University of Pennsylvania, has raised USD 50 Mn for the treatment of for cell-based autoimmune disease.

In January 2019, Banner Life Sciences LLC, a privately held specialty pharmaceutical company, has received tentative approval by the U.S. Food and Drug Administration (FDA) for BAFIERTAM developed for the treatment of relapsing forms of Multiple Sclerosis.

Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/autoimmune-disease-treatment-market-5586

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Jaw Surgery Market Analysis 2018 (By Segment, Key Players and Applications) and Forecasts To 2023

Market Synopsis of the Global Jaw Surgery Market

Jaw surgery, also known as orthognathic surgery, is a procedure used to correct a wide range of minor and major skeletal and dental irregularities. It is performed by qualified and skilled oral and maxillofacial surgeons (OMS). Patients with problems related to the jaws, facial asymmetries, and tooth alignment can undergo a jaw surgery. Indications for jaw surgery are maxillary and/or mandibular facial skeletal deformities, speech impairments, chronic jaw or jaw joint pain, facial trauma, and others. It is also used to correct protruding jaw, a congenital defect, or improve the overall facial appearance.

Increasing demand for jaw surgery, extensive use of jaw surgery instruments and devices and technological advancement in healthcare are the major drivers for the growth of the market. Furthermore, increasing healthcare expenditure and overall growth of healthcare industry has also influenced the market growth. Splendid research in the field of cosmetology also boost the market. However, the growth of the market is restrained by unawareness about the advantages of the procedure. Fierce competition among key players in the market restricts the entry of key players.

Additionally, increasing number of maxillary and mandibular surgeries also fuels the growth of the market across the globe.

The global jaw surgery market is expected to grow at a CAGR of 3.7% during the forecast period.

Key Players in the Global Jaw Surgery Market

Some of the key players in this market are Integra LifeSciences Corporation (U.S.), The Amato Centers for Facial Surgery (U.S.), The Restful Jaw Company, LLC. (U.S.), Millennium Surgical Corp (U.S.), Scanlan International. (U.S.), Novo Surgical Inc. (U.S.), HAAG-STREIT GROUP (U.S.), Eurosurgical (U.K), Sklar Surgical Instruments (U.S.), and others.

Segments

The global jaw surgery market is segmented on the basis of instruments, indication, and end user.

On the basis of instruments, market is segmented into curettes, elevators, forceps and needle holders, retractors and speculums, and others.

On the basis of indication, the market is segmented into maxillary and/or mandibular facial skeletal deformities, speech impairments, chronic jaw or jaw joint pain, facial trauma, and others.

On the basis of end user, the market is segmented into hospitals, clinics, and others.

Regional Analysis of the Global Jaw Surgery Market

America holds the first position in the market for jaw surgery owing to rising demand for jaw surgery and increasing number of clinics, and hospitals providing treatment for jaw surgery. In Americas, North America is the largest market owing to the presence of key player in the market that provide product and instruments for jaw surgery.

Europe is the second largest market for jaw surgery. In Europe, increasing expenditure on healthcare, growing economic support, and rising funding for research and development in healthcare also fuels the growth of the market. Germany and France are the biggest contributors to the growth of the market in Europe owing to the rising awareness about jaw surgery, and its advantages for improving facial appearance among the people. Additionally, overall growth of medical device industry further fuels the market growth.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the rising per capita income, increasing adoption of western culture has led the consumer inclination toward aesthetics, and growing demand for surgical procedures as a treatment option, due to a considerable prevalence of facial defects. China, and Japan are the major contributors of the growth of the market. This growth is attributed to an increasing demand of technologically advanced medical devices such as 3D imaging, and other orthodontic technologies, and availability of highly qualified medical personnel such as orthodontists and surgeons.

The Middle East & Africa also show a steady rise in the market owing to low technology penetration and increasing awareness about availability of surgical procedures in orthognathics and orthodontics. In the Middle East & Africa, Middle East captures the largest market share for jaw surgery owing to the availability of better healthcare infrastructure and a wide scope for research.

Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/jaw-surgery-market-5077

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com